C265H426N28O31 — CID 158219886
bis(2-[(E)-but-1-enyl]-5-(3-methoxycyclobutyl)oxypyridine);bis(2-[(E)-but-1-enyl]-5-(3-methoxycyclobutyl)oxypyrimidine);1-but-2-ynyl-4-[(3-methoxycyclobutyl)oxymethyl]piperidine;bis(2-but-1-ynyl-5-(3-methoxycyclobutyl)oxypyridine);bis(2-but-1-ynyl-5-(3-methoxycyclobutyl)oxypyrimidine);bis(2,7-diethyl-7-azaspiro[3.5]nonane);1-[(3-ethoxycyclobutyl)methyl]-4-ethylpiperidine;bis(1-[(3-ethoxycyclobutyl)oxymethyl]-4-ethylpiperazine);1-[(3-ethylcyclobutyl)methyl]-4-[(3-methoxycyclobutyl)oxymethyl]piperidine;4-ethyl-1-[(3-ethylcyclobutyl)methyl]piperidine;2-ethyl-5-(3-methoxycyclobutyl)oxypyridine;1-[(5-ethyl-2-pyridinyl)methyl]-4-[(3-methoxycyclobutyl)oxymethyl]piperazine;4-[(3-methoxycyclobutyl)oxymethyl]-1-[(1-methylazetidin-3-yl)methyl]piperidine (PubChem CID 158219886) has the molecular formula C265H426N28O31 and a molecular weight of 4500.49 g/mol. Its IUPAC name is bis(2-[(E)-but-1-enyl]-5-(3-methoxycyclobutyl)oxypyridine);bis(2-[(E)-but-1-enyl]-5-(3-methoxycyclobutyl)oxypyrimidine);1-but-2-ynyl-4-[(3-methoxycyclobutyl)oxymethyl]piperidine;bis(2-but-1-ynyl-5-(3-methoxycyclobutyl)oxypyridine);bis(2-but-1-ynyl-5-(3-methoxycyclobutyl)oxypyrimidine);bis(2,7-diethyl-7-azaspiro[3.5]nonane);1-[(3-ethoxycyclobutyl)methyl]-4-ethylpiperidine;bis(1-[(3-ethoxycyclobutyl)oxymethyl]-4-ethylpiperazine);1-[(3-ethylcyclobutyl)methyl]-4-[(3-methoxycyclobutyl)oxymethyl]piperidine;4-ethyl-1-[(3-ethylcyclobutyl)methyl]piperidine;2-ethyl-5-(3-methoxycyclobutyl)oxypyridine;1-[(5-ethyl-2-pyridinyl)methyl]-4-[(3-methoxycyclobutyl)oxymethyl]piperazine;4-[(3-methoxycyclobutyl)oxymethyl]-1-[(1-methylazetidin-3-yl)methyl]piperidine.
| Compound Name | bis(2-[(E)-but-1-enyl]-5-(3-methoxycyclobutyl)oxypyridine);bis(2-[(E)-but-1-enyl]-5-(3-methoxycyclobutyl)oxypyrimidine);1-but-2-ynyl-4-[(3-methoxycyclobutyl)oxymethyl]piperidine;bis(2-but-1-ynyl-5-(3-methoxycyclobutyl)oxypyridine);bis(2-but-1-ynyl-5-(3-methoxycyclobutyl)oxypyrimidine);bis(2,7-diethyl-7-azaspiro[3.5]nonane);1-[(3-ethoxycyclobutyl)methyl]-4-ethylpiperidine;bis(1-[(3-ethoxycyclobutyl)oxymethyl]-4-ethylpiperazine);1-[(3-ethylcyclobutyl)methyl]-4-[(3-methoxycyclobutyl)oxymethyl]piperidine;4-ethyl-1-[(3-ethylcyclobutyl)methyl]piperidine;2-ethyl-5-(3-methoxycyclobutyl)oxypyridine;1-[(5-ethyl-2-pyridinyl)methyl]-4-[(3-methoxycyclobutyl)oxymethyl]piperazine;4-[(3-methoxycyclobutyl)oxymethyl]-1-[(1-methylazetidin-3-yl)methyl]piperidine |
|---|---|
| PubChem CID | 158219886 |
| Molecular Formula | C265H426N28O31 |
| Molecular Weight | 4500.49 g/mol |
| Exact Mass | 4497.26 |
| IUPAC Name | bis(2-[(E)-but-1-enyl]-5-(3-methoxycyclobutyl)oxypyridine);bis(2-[(E)-but-1-enyl]-5-(3-methoxycyclobutyl)oxypyrimidine);1-but-2-ynyl-4-[(3-methoxycyclobutyl)oxymethyl]piperidine;bis(2-but-1-ynyl-5-(3-methoxycyclobutyl)oxypyridine);bis(2-but-1-ynyl-5-(3-methoxycyclobutyl)oxypyrimidine);bis(2,7-diethyl-7-azaspiro[3.5]nonane);1-[(3-ethoxycyclobutyl)methyl]-4-ethylpiperidine;bis(1-[(3-ethoxycyclobutyl)oxymethyl]-4-ethylpiperazine);1-[(3-ethylcyclobutyl)methyl]-4-[(3-methoxycyclobutyl)oxymethyl]piperidine;4-ethyl-1-[(3-ethylcyclobutyl)methyl]piperidine;2-ethyl-5-(3-methoxycyclobutyl)oxypyridine;1-[(5-ethyl-2-pyridinyl)methyl]-4-[(3-methoxycyclobutyl)oxymethyl]piperazine;4-[(3-methoxycyclobutyl)oxymethyl]-1-[(1-methylazetidin-3-yl)methyl]piperidine |
| SMILES | CC#CCN1CCC(COC2CC(OC)C2)CC1.CC/C=C/c1ccc(OC2CC(OC)C2)cn1.CC/C=C/c1ccc(OC2CC(OC)C2)cn1.CC/C=C/c1ncc(OC2CC(OC)C2)cn1.CC/C=C/c1ncc(OC2CC(OC)C2)cn1.CCC#Cc1ccc(OC2CC(OC)C2)cn1.CCC#Cc1ccc(OC2CC(OC)C2)cn1.CCC#Cc1ncc(OC2CC(OC)C2)cn1.CCC#Cc1ncc(OC2CC(OC)C2)cn1.CCC1CC(CN2CCC(COC3CC(OC)C3)CC2)C1.CCC1CC2(CCN(CC)CC2)C1.CCC1CC2(CCN(CC)CC2)C1.CCC1CCN(CC2CC(CC)C2)CC1.CCOC1CC(CN2CCC(CC)CC2)C1.CCOC1CC(OCN2CCN(CC)CC2)C1.CCOC1CC(OCN2CCN(CC)CC2)C1.CCc1ccc(CN2CCN(COC3CC(OC)C3)CC2)nc1.CCc1ccc(OC2CC(OC)C2)cn1.COC1CC(OCC2CCN(CC3CN(C)C3)CC2)C1 |
| InChI | InChI=1S/C18H29N3O2.C18H33NO2.C16H30N2O2.C15H25NO2.2C14H19NO2.2C14H17NO2.C14H27NO.C14H27N.2C13H18N2O2.2C13H16N2O2.2C13H26N2O2.C12H17NO2.2C12H23N/c1-3-15-4-5-16(19-12-15)13-20-6-8-21(9-7-20)14-23-18-10-17(11-18)22-2;1-3-14-8-16(9-14)12-19-6-4-15(5-7-19)13-21-18-10-17(11-18)20-2;1-17-9-14(10-17)11-18-5-3-13(4-6-18)12-20-16-7-15(8-16)19-2;1-3-4-7-16-8-5-13(6-9-16)12-18-15-10-14(11-15)17-2;4*1-3-4-5-11-6-7-12(10-15-11)17-14-8-13(9-14)16-2;1-3-12-5-7-15(8-6-12)11-13-9-14(10-13)16-4-2;1-3-12-5-7-15(8-6-12)11-14-9-13(4-2)10-14;4*1-3-4-5-13-14-8-12(9-15-13)17-11-6-10(7-11)16-2;2*1-3-14-5-7-15(8-6-14)11-17-13-9-12(10-13)16-4-2;1-3-9-4-5-10(8-13-9)15-12-6-11(7-12)14-2;2*1-3-11-9-12(10-11)5-7-13(4-2)8-6-12/h4-5,12,17-18H,3,6-11,13-14H2,1-2H3;14-18H,3-13H2,1-2H3;13-16H,3-12H2,1-2H3;13-15H,5-12H2,1-2H3;2*4-7,10,13-14H,3,8-9H2,1-2H3;2*6-7,10,13-14H,3,8-9H2,1-2H3;12-14H,3-11H2,1-2H3;12-14H,3-11H2,1-2H3;2*4-5,8-11H,3,6-7H2,1-2H3;2*8-11H,3,6-7H2,1-2H3;2*12-13H,3-11H2,1-2H3;4-5,8,11-12H,3,6-7H2,1-2H3;2*11H,3-10H2,1-2H3/b;;;;2*5-4+;;;;;2*5-4+;;;;;;; |
| InChIKey | GDCRXAKRHAKSAG-BQCUGJMSSA-N |
| XLogP | 44.85 |
| TPSA | 511.95 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 59 |
| Rotatable Bonds | 86 |
| Heavy Atoms | 324 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 4500.49 |
| LogP ≤ 5 | 44.85 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 59 |